The gold-standard method for quantitating the degree of insulin resistance (i.e., the euglycemic-hyperinsulinemic clamp procedure) was discussed to provide a background for the correct assessment of insulin secretion in patients with prediabetes and T2DM under various therapies. The gene discussed is INS; the disease is prediabetes syndrome.